BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36166332)

  • 1. Inflammation and heart failure: a two-sample Mendelian randomization study.
    Remmelzwaal S; van Oort S; Handoko ML; van Empel V; Heymans SRB; Beulens JWJ
    J Cardiovasc Med (Hagerstown); 2022 Nov; 23(11):728-735. PubMed ID: 36166332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Mendelian randomization study investigating the causal role of inflammation on Parkinson's disease.
    Bottigliengo D; Foco L; Seibler P; Klein C; König IR; Del Greco M F
    Brain; 2022 Oct; 145(10):3444-3453. PubMed ID: 35656776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study.
    Hartwig FP; Borges MC; Horta BL; Bowden J; Davey Smith G
    JAMA Psychiatry; 2017 Dec; 74(12):1226-1233. PubMed ID: 29094161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of C-reactive protein on the risk of Heart failure: a mendelian randomization study.
    Habibi D; Daneshpour MS; Asgarian S; Kohansal K; Hadaegh F; Mansourian M; Akbarzadeh M
    BMC Cardiovasc Disord; 2023 Mar; 23(1):112. PubMed ID: 36882679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between inflammation and cognition: Triangulation of evidence using a population-based cohort and Mendelian randomization analyses.
    Slaney C; Sallis HM; Jones HJ; Dardani C; ; Tilling K; Munafò MR; Davey Smith G; Mahedy L; Khandaker GM
    Brain Behav Immun; 2023 May; 110():30-42. PubMed ID: 36791891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic liability between COVID-19 and heart failure: evidence from a bidirectional Mendelian randomization study.
    Wang H; Guo Z; Zheng Y; Chen B
    BMC Cardiovasc Disord; 2022 Jun; 22(1):262. PubMed ID: 35690714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory biomarkers and risk of ischemic stroke and subtypes: A 2-sample Mendelian randomization study.
    Lin J; Wang Y; Wang Y; Pan Y
    Neurol Res; 2020 Feb; 42(2):118-125. PubMed ID: 31900081
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study.
    Guo W; Zhao L; Huang W; Chen J; Zhong T; Yan S; Hu W; Zeng F; Peng C; Yan H
    Cardiovasc Diabetol; 2024 Apr; 23(1):118. PubMed ID: 38566143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study.
    Prins BP; Abbasi A; Wong A; Vaez A; Nolte I; Franceschini N; Stuart PE; Guterriez Achury J; Mistry V; Bradfield JP; Valdes AM; Bras J; Shatunov A; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Lu C; Han B; Raychaudhuri S; Bevan S; Mayes MD; Tsoi LC; Evangelou E; Nair RP; Grant SF; Polychronakos C; Radstake TR; van Heel DA; Dunstan ML; Wood NW; Al-Chalabi A; Dehghan A; Hakonarson H; Markus HS; Elder JT; Knight J; Arking DE; Spector TD; Koeleman BP; van Duijn CM; Martin J; Morris AP; Weersma RK; Wijmenga C; Munroe PB; Perry JR; Pouget JG; Jamshidi Y; Snieder H; Alizadeh BZ
    PLoS Med; 2016 Jun; 13(6):e1001976. PubMed ID: 27327646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causal relationships between inflammatory factors and multiple myeloma: A bidirectional Mendelian randomization study.
    Wang Q; Shi Q; Lu J; Wang Z; Hou J
    Int J Cancer; 2022 Nov; 151(10):1750-1759. PubMed ID: 35841389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically Determined Inflammatory Biomarkers and the Risk of Heart Failure: A Mendelian Randomization Study.
    Li X; Peng S; Guan B; Chen S; Zhou G; Wei Y; Gong C; Xu J; Lu X; Zhang X; Liu S
    Front Cardiovasc Med; 2021; 8():734400. PubMed ID: 34881299
    [No Abstract]   [Full Text] [Related]  

  • 12. Mendelian randomization analysis of C-reactive protein on colorectal cancer risk.
    Wang X; Dai JY; Albanes D; Arndt V; Berndt SI; Bézieau S; Brenner H; Buchanan DD; Butterbach K; Caan B; Casey G; Campbell PT; Chan AT; Chen Z; Chang-Claude J; Cotterchio M; Easton DF; Giles GG; Giovannucci E; Grady WM; Hoffmeister M; Hopper JL; Hsu L; Jenkins MA; Joshi AD; Lampe JW; Larsson SC; Lejbkowicz F; Li L; Lindblom A; Le Marchand L; Martin V; Milne RL; Moreno V; Newcomb PA; Offitt K; Ogino S; Pharoah PDP; Pinchev M; Potter JD; Rennert HS; Rennert G; Saliba W; Schafmayer C; Schoen RE; Schrotz-King P; Slattery ML; Song M; Stegmaier C; Weinstein SJ; Wolk A; Woods MO; Wu AH; Gruber SB; Peters U; White E
    Int J Epidemiol; 2019 Jun; 48(3):767-780. PubMed ID: 30476131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causal Relationship Between Inflammation and Preeclampsia: Genetic Evidence from a Mendelian Randomization Study.
    Zhong Q; Yao C; Zhong W
    Twin Res Hum Genet; 2023 Jun; 26(3):231-235. PubMed ID: 37458219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Genetically Predicted Fibroblast Growth Factor-23 with Heart Failure: A Mendelian Randomization Study.
    Akwo E; Pike MM; Ertuglu LA; Vartanian N; Farber-Eger E; Lipworth L; Perwad F; Siew E; Hung A; Bansal N; de Boer I; Kestenbaum B; Cox NJ; Ikizler TA; Wells Q; Robinson-Cohen C
    Clin J Am Soc Nephrol; 2022 Aug; 17(8):1183-1193. PubMed ID: 35902130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between circulating inflammatory factors and autism spectrum disorder: a bidirectional Mendelian randomization study in European population.
    Long J; Dang H; Su W; Moneruzzaman M; Zhang H
    Front Immunol; 2024; 15():1370276. PubMed ID: 38742104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
    Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
    EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mendelian randomization study for the roles of IL-18 and IL-1 receptor antagonist in the development of inflammatory bowel disease.
    Mi J; Liu Z; Pei S; Wu X; Zhao N; Jiang L; Zhang Z; Bai X
    Int Immunopharmacol; 2022 Sep; 110():109020. PubMed ID: 35843146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of the circulating levels of cytokines with the risk of myeloproliferative neoplasms: a bidirectional mendelian-randomization study.
    Xiong H; Zhang H; Bai J; Li Y; Li L; Zhang L
    BMC Cancer; 2024 Apr; 24(1):531. PubMed ID: 38671390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the genetic basis of the causal association between inflammatory cytokines and osteonecrosis.
    Lu Y; Pei Y; Gao Y; Zhao F; Wang L; Zhang Y
    Front Endocrinol (Lausanne); 2024; 15():1344917. PubMed ID: 38745949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity C-reactive protein, low-grade systemic inflammation and type 2 diabetes mellitus: A two-sample Mendelian randomization study.
    Noordam R; Oudt CH; Bos MM; Smit RAJ; van Heemst D
    Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):795-802. PubMed ID: 29753585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.